News
Updates on activities and accomplishments at AYOXXA
As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.
Conferences
Meet AYOXXA
AYOXXA @ ARVO 2018 Annual Meeting
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics research in ophthalmology, will participate in the upcoming ARVO 2018, the Annual Meeting of the American Association for Research in Vision and Ophthalmology.
Read morePress Reviews
Press Review
Why did you name your company AYOXXA Biosystems?
Interview with Wolfgang Kintzel (Co-CEO) and Dr. Markus Zumbansen (CTO), both from AYOXXA Biosystems. Article published in German language.
Read more
Press Review
Sandwich on beads
Cologne-based AYOXXA Biosystems counts on the simultaneous quantification of Cytokines and other biomarkers, captured by antibody-coated microbeads. Company profile authored by Sigrid März, Freelancer for Laborjournal. Read full-text company profile in German language.
Read more
Press Review
AYOXXA launches LUNARIS Protein Analysis System in Asia
Founded in 2010 as a spin-off of the National University of Singapore, AYOXXA Biosystems is one of the success stories of Singapore’s Biotech start-up community. It has since grown into a global biotech company headquartered in Cologne, Germany, and it remains focused on the development and commercialization of its proprietary technology for advanced protein analysis, LUNARIS™. AYOXXA Living Health Technologies Pte.
Read morePress Releases
Press Release
AYOXXA launches LUNARIS™ Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human 12-Plex Th17 Kit for the quantitative validation of soluble pro-inflammatory T helper 17 (Th17) cell-related markers.
Read more
Press Release
AYOXXA @ BIO-Europe Spring 2018 - 12th International Partnering Conference
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, will participate in the upcoming BIO-Europe Spring®
Read more
Press Release
AYOXXA launches LUNARIS™ Human 11-Plex Ophthalmology Kit
For multiplexed analysis of biomarker signatures in ocular fluids including vitreous and aqueous samples. Covering: angiogenic & inflammatory factors, chemokines known to be relevant in the pathology of retinal angiogenic diseases next to VEGF, the target molecule of today’s standard of care.
Read more